Ellington Management Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-46,300
Closed -$710K 760
2018
Q1
$710K Buy
46,300
+28,500
+160% +$407K 0.05% 316
2017
Q4
$205K Buy
+17,800
New +$265K 0.03% 481
2017
Q3
Sell
-11,700
Closed -$282K 798
2017
Q2
$282K Sell
11,700
-4,100
-26% -$89.9K 0.04% 420
2017
Q1
$313K Buy
+15,800
New +$353K 0.01% 452
2016
Q1
Sell
-14,126
Closed -$422K 649
2015
Q4
$422K Buy
+14,126
New +$476K 0.15% 179

Other funds holding PGEN

Ellington Management Group's PGEN Position: Q2 2018 in Review

Ellington Management Group sold out of Precigen (PGEN) in Q2 2018, closing a stake of 46,300 shares — an estimated $710K sold.

Ellington Management Group first reported a position in PGEN in Q4 2015 and held it in 5 quarters. The position peaked at $710K in Q1 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q2 2018.

  • Ellington Management Group reported no remaining Precigen position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 46,300 Precigen shares in Q2 2018, an estimated $710K.
  • Ellington Management Group first reported a position in Precigen in Q4 2015 and held it in 5 quarters.
  • Ellington Management Group's Precigen position peaked at $710K in Q1 2018.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.